tranylcypromine has been researched along with dantrolene in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alampi, D; Capelli, O; Castagna, A; Di Placido, G; Lappa, A; Podestà , M; Semeraro, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
3 other study(ies) available for tranylcypromine and dantrolene
| Article | Year |
|---|---|
Successful treatment of a complicated case of neuroleptic malignant syndrome.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Dantrolene; Disseminated Intravascular Coagulation; Female; Fluid Therapy; Humans; Infusions, Intravenous; Italy; Monoamine Oxidase Inhibitors; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Rhabdomyolysis; Tranylcypromine; Treatment Outcome; Trifluoperazine | 2002 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |